(HealthDay)—Newly approved anticancer drugs that do not have a specific molecular target on cancer cells are associated with increased toxicity and the accompanying costs of management, according to research ...
12 hours ago
not rated yet | 0
An official at a life sciences startup based on a Purdue University innovation says his company may help oncologists see faster than ever which drug therapies will benefit cancer patients and to what extent.
22 hours ago
5 / 5 (1) | 0